Novartis AG is 2.6x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($283.13 B vs $110.46 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VRTX | NVS |
|---|---|---|
| Market cap | $110.46 B | $283.13 B |
| US-listed rank | #136 | #47 |
| Revenue (latest FY) | $12.00B | - |
| Net income (latest FY) | $3.95B | - |
| Net margin | 32.9% | - |
| P/E (trailing FY) | 27.9 | - |
| SEC filings | 1,000 | 947 |
Novartis AG is 2.6x more valuable than VERTEX PHARMACEUTICALS INC / MA by market capitalization ($283.13 B vs $110.46 B).
Full pages: VERTEX PHARMACEUTICALS INC / MA and Novartis AG, or browse the full rankings.